HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ACC Submits Plan To Help EPA Prioritize Chemicals For TSCA Review

This article was originally published in The Rose Sheet

Executive Summary

The American Chemistry Council has unveiled a new “scientifically based” system to prioritize chemicals for regulatory review.

You may also be interested in...



Lautenberg Unveils TSCA Reform Bill, Putting Safety Burden-Of-Proof On Industry

Sen. Frank R. Lautenberg, D-N.J., introduced legislation April 14 updating the 35-year-old Toxic Substances Control Act to set the responsibility for chemical safety substantiation squarely on manufacturers’ shoulders.

Elections Create More Favorable Environment For Council’s Regulatory Plan

The shift in House leadership following the recent elections could make it more difficult for the Campaign for Safe Cosmetics-backed Safe Cosmetics Act to pass through Congress, presenting opportunity for industry-supported legislation.

The Replacements: Cosmetic Ingredient Suppliers At Ready With Microplastic Alternatives As EU Ban Unfolds

HBW Insight reached out to suppliers of microplastic alternatives for cosmetics use to discuss their offerings and preparedness for demand surges under phased REACH prohibitions.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel